Literature DB >> 20001654

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

Giuseppe Mancia1, Stéphane Laurent, Enrico Agabiti-Rosei, Ettore Ambrosioni, Michel Burnier, Mark J Caulfield, Renata Cifkova, Denis Clément, Antonio Coca, Anna Dominiczak, Serap Erdine, Robert Fagard, Csaba Farsang, Guido Grassi, Hermann Haller, Antony Heagerty, Sverre E Kjeldsen, Wolfgang Kiowski, Jean Michel Mallion, Athanasios Manolis, Krzysztof Narkiewicz, Peter Nilsson, Michael H Olsen, Karl Heinz Rahn, Josep Redon, José Rodicio, Luis Ruilope, Roland E Schmieder, Harry A J Struijker-Boudier, Pieter A Van Zwieten, Margus Viigimaa, Alberto Zanchetti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20001654     DOI: 10.3109/08037050903450468

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


× No keyword cloud information.
  86 in total

1.  Newer is not always better: all antihypertensive medications do not equally reduce cardiovascular risk.

Authors:  Gerald W Smetana
Journal:  J Gen Intern Med       Date:  2012-06       Impact factor: 5.128

Review 2.  Systolic pressure, diastolic pressure, or pulse pressure as a cardiovascular risk factor in renal disease.

Authors:  José A García-Donaire; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

3.  [Diabetes mellitus and cardiovascular risk. Is integrated therapy of type 2 diabetes and cardiovascular risk factors necessary?].

Authors:  Domingo Orozco Beltrán; Carlos de la Sen Fernández; Vicente Gil Guillén; Concepción Carratalá Munuera; Jorge Navarro Pérez
Journal:  Aten Primaria       Date:  2010-09       Impact factor: 1.137

4.  Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent Restenosis.

Authors:  Giuliano Tocci; Emanuele Barbato; Roberta Coluccia; Anna Modestino; Beniamino Pagliaro; Vittoria Mastromarino; Francesca Giovannelli; Andrea Berni; Massimo Volpe
Journal:  Am J Hypertens       Date:  2015-08-13       Impact factor: 2.689

5.  HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.

Authors:  Gino Seravalle; Nevrez Koylan; Istemi Nalbantgil; Nail Caglar; Fosca Quarti-Trevano; Wim Makel; Guido Grassi; Francesco Fici
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-22

6.  Should thiazide diuretics be given as first line antihypertensive therapy or in addition to other medications?

Authors:  Valentina Trimarco; Raffaele Izzo; Teresa Migliore; Francesco Rozza; Marina Marino; Maria Virginia Manzi; Marina De Marco; Giovanni de Simone; Nicola De Luca
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-06-24

Review 7.  Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence.

Authors:  Massimo Volpe; Giuliano Tocci
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

Review 8.  Pre-hypertension: how low to go and do drugs have a role?

Authors:  Gordon McInnes
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

9.  Hypertension in women: latest findings and clinical implications.

Authors:  Helga Gudmundsdottir; Aud Høieggen; Aud Stenehjem; Bård Waldum; Ingrid Os
Journal:  Ther Adv Chronic Dis       Date:  2012-05       Impact factor: 5.091

Review 10.  Role of olmesartan in combination therapy in blood pressure control and vascular function.

Authors:  Carlos M Ferrario; Ronald D Smith
Journal:  Vasc Health Risk Manag       Date:  2010-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.